Cardiac autonomic neuropathy in patients with chronic renal failure on hemodialysis

Nephron

Volumn 84, Issue 4, 2000, Pages 312-319

  Kurata, Chinori ^a   Uehara, Akihiko ^a   Sugi, Toshihiko ^a   Ishikawa, Akira ^a   Fujita, Kimio ^a   Yonemura, Katsuhiko ^a   Hishida, Akira ^a   Ishikawa, Keiko ^a   Tawarahara, Kei ^b   Shouda, Sakae ^b   Mikami, Tadashi ^b  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hamamatsu Red Cross Hospital   (Japan)

Author keywords

Cardiac autonomic nervous system; Catecholamine; Chronic renal failure; Heart rate variability; Lung; Metaiodobenzylguanidine

Indexed keywords

(3 IODOBENZYL)GUANIDINE; ADRENALIN; CATECHOLAMINE; DOPAMINE; IODINE 123; NORADRENALIN;

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; CATECHOLAMINE BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLEARANCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART MUSCLE; HEART RATE VARIABILITY; HEART SCINTISCANNING; HEMODIALYSIS; HUMAN; LUNG; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0034110743     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045605     Document Type: Article

References (53)

1. Kersch ES, Kronfield SJ, Unger A, Popper RW, Cantor S, Cohn K: Autonomic insufficiency in uremia as a cause of hemodialysis-induced hypotension. N Engl J Med 1974;290: 650-653.
2. Ewing DJ. Winney R: Autonomic function in patients with chronic renal failure on intermittent hemodialysis. Nephron 1975;15:424-429.
3. Campese VM, Romoff MS, Levitan D, Lane K, Massry SG: Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int 1981;20:246-253.
4. Kheder MA, Ben Maïz H, Abderrahim E, el Younsi F, Ben Moussa F, Safar ME, Ben Ayed H: Hypertension in primary chronic glomerulonephritis analysis of 359 patients. Nephron 1993;63:140-144.
5. London GM, Fabiani F, Marchasi SJ, De Vernejoul MC, Guerin AP, Safar ME, Metivier F, Llach F: Uremic cardiomyopathy: An inadequate left ventricular hypertrophy. Kidney Int 1987;31:973-980.
6. Burt RK, Gupta-Burt S, Suki WN, Barcenas CG, Ferguson JJ, Van Buren CT: Reversal of left ventricular dysfunction after renal transplantation. Ann Intern Med 1989;111:635-640.
7. Izzo JL Jr, Izzo MS, Sterns RH, Freeman RB: Sympathetic nervous system hyperactivity in maintenance hemodialysis patients. Trans Am Soc Artif Intern Organs 1982;28:604-607.
8. Converse RL Jr, Jacobson TN, Toto RD, Jost CMT, Cosentino F, Fouad-Tarazi F, Victor RG: Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992;327: 1912-1918.
9. Forsström J, Forsström, J. Heinonen E. Välimäki I, Antila K: Effects of haemodialysis on heart rate variability in chronic renal failure. Scand J Clin Lab Invest 1986;46:665-670.
10. Axelrod S, Lishner M, Oz O, Bernheim J, Ravid M: Spectral analysis of fluctuations in heart rate: An objective evaluation of autonomic nervous control in chronic renal failure. Nephron 1987;45:202-206.
11. Thomson BJ, McAreavey D, Neilson JMM, Winney RJ, Ewing DJ: Heart rate variability and cardiac arrhythmias in patients with chronic renal failure. Clin Auton Res 1991;1: 131-133.
12. Cloarec-Blanchard L, Girard A, Houhou S, Grünfeld J-P, Elghozi J-L: Spectral analysis of short-term blood pressure and heart rate variability in uremic patients. Kidney Int 1992; 37(suppl 2):14-18.
13. Ksiazek A: Beta dopamine hydroxylase activity and catecholamine levels in the plasma of patients with renal failure. Nephron 1979;24: 170-174.
14. Rascher W, Schrömig A, Kreye VA, Ritz E: Diminished vascular response to noradrenaline in experimental chronic uremia. Kidney Int 1982;21:20-27.
15. 123I-metaiodobenzylguanidine from the heart in patients with chronic renal failure on dialysis. J Nucl Med 1995;36: 2037-2043.
16. 43K and the scintillation camera. Circ Res 1973;33:113-122.
17. 123l-metaiodobenzyl-guanidine kinetics with heart rate variability and plasma norepinephrine level. J Nucl Cardiol 1997;4:515-523.
18. Uehara A, Kurata C, Sugi T, Mikami T, Shouda S: Diabetic cardiac autonomic dysfunction: Parasympathetic versus sympathetic. Ann Nucl Med 1999;13:95-100.
19. Task Force of European Society of Cardiology and North American Society of Pacing and Electrophysiology: Heart rate variability: Standards and measurement, physiological interpretation, and clinical use. Circulation 1996; 93:1043-1065.
20. Fukuda S, Kobayashi H, Mochizuki T, Tanaka M, Yokoyama Y, Hattori N: Plasma dopamine, urinary dopamine and their metabolites in chronic renal failure. Jpn J Nephrol 1992;34: 1011-1017.
21. Hörl WH, Riegel W: Cardiac depressant factors in renal disease. Circulation 1993;87(suppl IV):77-82.
22. Benedict CR, Shelton B, Johnstone DE, Francis G, Greenverg B, Konstant M, Probstfield JL, Yusuf S: Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation 1996; 94:690-697.
23. Malliani A, Pagani M, Lombardi F, Cerutti S: Cardiovascular neural regulation explored in the frequency domain. Circulation 1991;84: 482-492.
24. Van de Borne P, Montano N, Pagani M, Oren R, Somers VK: Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 1997;95:1449-1454.
25. Pagani M, Malfatto G, Pierini S, Casati R. Masu AM, Poli M, Guzzetti S, Lombardi F, Cerutti S, Malliani A: Spectral anaylsis of heart rate variability in the assessment of autonomic diabetes neuropathy. J Auton Nerv Syst 1988; 23:143-153.
26. Hayano J, Sakakibara Y, Yamada M, Ohte N, Fujinami T, Yokoyama K, Watanabe Y, Takata K: Decreased magnitude of heart rate spectral components in coronary artery disease. Circulation 1990,81:1217-1224.
27. 123I-MIBG. J Nuel Med 1999;40:6-11.
28. Huikuri HV, Ylitalo A, Pikkujamsa SM, Ikaheimo MJ, Airaksinen KE, Rantala AO, Lilja M, Kesaniemi YA: Heart rate variability in systemic hypertension. Am J Cardiol 1998;32: 293-297.
29. Henderson EB, Kahn JK, Corbett JR, Jansen De, Pippin JJ, Kulkarni P, Ugolini V, Akers MS, Hansen C, Buja LM, Parkey RW, Willerson JT: Abnormal 1-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988;78:1192-1199.
30. Schofer J, Spielmann R, Schuchert A, Weber K, Schulter M: Iodine-123 meta-iodobenzyl-guanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988;12:1252-1258.
31. 123I]metaiodobenzyl-guanidine scintigraphy. Circulation 1994;89: 2843-2851.
32. Langer A, Freeman MR, Josse RG, Armstrong PW: Metaidobenzylguanidine imaging in diabetes mellitus: Assessment of cardiac sympathetic denervation and its relation to autonomie dysfunction and silent myocardial ischemia. J Am Coll Cardiol 1995;25:610-618.
33. 123I-MIBG after acute myocardial infarction and reperfusion therapy. J Nucl Med 1990;40:904-910.
34. Kuwahara T, Hamada M, Hiwada K: Direct evidence of impaired cardiac sympathetic innervation in essential hypertensive patients with left ventricular hypertrophy. J Nucl Med 1998;39:1486-1491.
35. 123I-labeled metaiodobenzylguanidine in patients with chronic renal failure and autonomic dysfunction. J Nucl Cardiol 1996;3:508-515.
36. Gill JS, Hunter GJ, Gane G, Camm AJ: Heterogeneity of the human myocardial sympathetic innervation: In vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy. Am Heart J 1993;126:390-398.
37. Morozumi T, Kusuoka H, Fukuchi K, Tani A, Uehara T, Matsuda S, Tsujimura E, Ito Y, Hori M, Kamada T, Nishimura T: Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med 1997;38:49-52.
38. Dae MW, Lee RJ, Ursell PC, Chin MC, Stillson CA, Moise NS: Heterogeneous sympathetic innervation in German shepherd dogs with inherited ventricular arrhythmia and sudden cardiac death. Circulation 1997;96:1337-1342.
39. Eisenhofer G, Smolich JJ, Esler MD: Different desipramine-sensitive pulmonary removals of plasma epinephrine and norepinephrine in dogs. Am J Physiol 1992;262:L360-L365.
40. 131I-metaiodobenzylguanidine uptake in the isolated rat lung: A potential markers of endothelial cell function. Eur J Nucl Med 1988; 13:543-547.
41. Ünlü M, Inanir S: Prolonged lung retention of iodine-123-MIBG in diabetic patients. J Nucl Med 1998;39:116-118.
42. Murashima S, Takeda K, Matsumura K. Yamakado K, Sakuma H, Kitano T, Nakagawa T, Ichihara T, Yamakado T, Murata K: Increased lung uptake of iodine-123-MIBG in diabetics with sympathetic nervous dysfunction. J Nucl Med 1998;39:334-338.
43. 123I-MIBG pulmonary removal: A biochemical marker of minimal lung endothelial cell lesions. Eur J Nucl Med 1990;16:633-637.
44. Suga K, Kume N, Shimizu K, Nishigauchi K, Hara A, Motoyama K, Matsunaga N: Potential of iodine-123 metaiodobenzylguanidine single-photon emission tomography to detect abnormal function status of the pulmonary neuroadrenergic system in irradiated lung. Eur J Nucl Med 1999;26:647-654.
45. Lee YS: Ultrastructural observations of chronic uremic lungs with special reference to histochemical and X-ray microanalytic studies on altered alveolocapillary basement membranes. Am J Nephrol 1985;5:255-266.
46. Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GL, Esler MD: Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 1994;90:234-240.
47. Huikuri HV, Kessler KM, Terracall E, Castellanos A, Linnaluoto MK, Myerburg RJ: Reproducibility and circadian rhythm of heart rate variability in healthy subjects. Am J Cardiol 1990;65:391-393.
48. Van Hoogenhuyze D, Weinstein N, Martin GJ, Weiss JS, Schaad JW, Sahyouni XN, Fintel D, Remme WJ, Singer DH: Reproducibility and relation to mean heart rate of heart rate variability in normal subjects and in patients with congestive heart failure secondary to coronary artery disease. Am J Cardiol 1991:68:1668-1676.
49. Stein PK, Rich MW, Rottman JN, Kleiger RE: Stability of index heart rate variability in patients with congestive heart failure. Am Heart J 1995;129:975-981.
50. Rubinger D, Sapoznikov D. Pollak A, Popovtzer MM, Luria MH: Heart rate variability during chronic hemodialysis and after renal transplantation: Studies in patients without and with systemic amyloidosis. J Am Soc Nephrol 1999;10:1972-1981.
51. Merlet P, Valette H, Dubois-Randé JL, Moyse D, Duboc D, Dove P, Bourguignon MH, Benvenuti C, Duval AM, Agostini D, Loisance D, Castaigne A, Syrota A: Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33: 471-477.
52. Stein KM, Borer JS, Hochreiter C, Okin PM, Herrold EM, Devercux RB, Kligfield P: Prognostic value and physiological correlates of heart rate variability in chronic severe mitral regurgitation. Circulation 1993;88:127-135.
53. Ponikowski P, Anker SD, Chua TP, Szelemej R, Piepoli M, Adamopoulos S, Webb-Peploe K, Harrington D, Banasiak W, Wrabec K, Coats AJ: Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997;79:1645-1650.